case_images: PMC11014721_01
case_images: Fundus photography and horizontal OCT at initial and postoperative examination in case 1. a Fundus photograph of the right eye with a MH. b Fundus photograph of the left eye. c Fundus photograph of the right eye on postoperative day 18. d Fundus photograph of the right eye on postoperative month 3. e Fundus photograph of the right eye on postoperative month 6. f Fundus photograph of the right eye on postoperative year 1. g OCT of the right eye with a MH. OCT showing a minimal diameter (*) of 286 mum and maximal diameter (arrowhead) of 910 mum; with a full-thickness neurosensory defect at the macula, there is the presence of cystic changes involving the margins of dehiscence. h OCT of the left eye. i OCT of the right eye performed on postoperative day 4. OCT showing a minimal diameter (*) of 306 mum and maximal diameter (arrowhead) of 656 mum, the presence of full-thickness defect at the macula along with cystoid changes. j OCT of the right eye performed on postoperative day 18. OCT showing a minimal diameter (*) of 290 mum and maximal diameter (arrowhead) of 1,502 mum, the presence of full-thickness defect at the macula along with cystoid changes. The cystic changes are worsening. k Postoperative month 1. With the disappearance of edema, the rim of the MH is attached and the MH is closed. The residual pocket of subretinal fluid is remained. l OCT of the right eye performed on postoperative month 3. OCT reveals disappearance of the subretinal fluid. m OCT of the right eye performed on postoperative month 6. n OCT of the right eye performed on postoperative year 1.
case_images: cop-2024-0015-0001-538026_F01.jpg
case_images: PMC11014721_01_cop-2024-0015-0001-538026_F01.jpg
case_images: F1
case_images: Slit-lamp examination and optical coherence tomography (OCT) revealed a Gass Stage 3 MH in the right eye, without diabetic retinopathy or maculopathy in either eye (shown in Fig. 1a, b, g, h). OCT performed on postoperative day 4 (shown in Fig. 1i) revealed that the MH was open, with slight edema at its edge. OCT on postoperative day 18 (shown in Fig. 1c, j) revealed that the ILM flap remained in the MH; however, the edema at the edge of the MH had worsened. OCT showed a minimal diameter (*) of 290 mum and maximal diameter (arrowhead) of 1,502 mum. OCT performed 2 weeks after STTA injection (postoperative month 1) indicated that the macular edema had disappeared (shown in Fig. 1k); further, MH closure has been achieved. However, the residual pocket of subretinal fluid remained until the sixth postoperative month, with the MH remaining closed (shown in Fig. 1d, e, l, m) and the BCVA of the right eye improving to 20/100. One year after surgery, OCT revealed disappearance of the subretinal fluid, and the BCVA remained at 20/100 (shown in Fig. 1f, n).
case_images: PMC11014721_02
case_images: Fundus photograph and horizontal OCT at initial and postoperative examination in case 1. a Fundus photograph of the right eye. b Fundus photograph of the left eye with a MH. c Fundus photograph of the left eye on postoperative day 18. d Fundus photograph of the left eye on postoperative month 2. e Fundus photograph of the left eye on postoperative month 4. f Fundus photograph of the left eye on postoperative month 6. g OCT of the right eye. h OCT of the left eye with a MH. OCT showing a minimal diameter (*) of 312 mum and maximal diameter (arrowhead) of 555 mum; with a full-thickness neurosensory defect at the macula, there is the presence of cystic changes involving the margins of dehiscence. i OCT of the left eye on postoperative day 5. OCT showing the presence of full-thickness defect at the macula. j OCT of the left eye on postoperative day 18. OCT showing a minimal diameter (*) of 221 mum and maximal diameter (arrowhead) of 959 mum, the presence of full-thickness defect at the macula along with cystoid changes. k OCT of the left eye on postoperative day 25. OCT showing a minimal diameter (*) of 189 mum and maximal diameter (arrowhead) of 885 mum, the presence of full-thickness defect at the macula along with cystoid changes. The cystic changes are worsening. l OCT of the left eye on postoperative month 2. OCT showing a maximal diameter (arrowhead) of 663 mum; with the disappearance of edema, the rim of the MH is attached and the MH is closed. The residual pocket of subretinal fluid is remained. m OCT of the left eye on postoperative month 4. OCT showing a maximal diameter (arrowhead) of 663 mum. n OCT of the left eye on postoperative month 6. OCT showing a maximal diameter (arrowhead) of 242 mum. Subretinal fluid is decreased, and the MH remains closed.
case_images: cop-2024-0015-0001-538026_F02.jpg
case_images: PMC11014721_02_cop-2024-0015-0001-538026_F02.jpg
case_images: F2
case_images: Stage 3 MH in the left eye (shown in Fig. 2a, b, g, h). OCT showed that the minimal diameter of the MH was 312 mum and the maximal diameter was 555 mum. She underwent PPV, ILM translocation, and SF6 gas injection with cataract surgery in the left eye. OCT performed on postoperative day 5 (shown in Fig. 2i) revealed that the MH was open. On postoperative day 18, fundus examination and OCT (shown in Fig. 2c, j) revealed that the ILM flap remained in the MH; however, edema was observed at the edge of the MH. One week after STTA injection (postoperative day 25), the macular edema persisted and the MH remained open (shown in Fig. 2k). OCT showed that the MH was closed; however, the residual pocket of subretinal fluid persisted (shown in Fig. 2d, l), but BCVA improved to 20/100. OCT revealed remaining subretinal fluid at 4 postoperative months (3 months after STTA) (shown in Fig. 2e, m). OCT showed a maximal diameter (arrowhead) of 663 mum. OCT revealed the subretinal fluid was decreased and the MH remained closed (shown in Fig. 2f, n), and the BCVA of the left eye remained 20/100. OCT showed a maximal diameter (arrowhead) of 242 mum.